RMTI Rockwell Medical Inc.

2.16
+0.07  (+3%)
Previous Close 2.09
Open 2.09
Price To Book 5.84
Market Cap 138,144,729
Shares 63,955,893
Volume 231,721
Short Ratio
Av. Daily Volume 324,419
Stock charts supplied by TradingView

NewsSee all news

  1. Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

    WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  2. Rockwell Medical, Inc. Expands Medical Capabilities

    – Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov.

  3. Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

    – Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program –  – Signs leading East Coast academic medical center as first

  4. Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference

    WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  5. Rockwell Medical, Inc. to Discuss Third Quarter 2019 Financial Results on November 11, 2019

    WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (NASDAQ:RMTI) today announced that the Company will release its 2019 third quarter financial results on

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Anemia
PDUFA date March 28, 2020.
IV Triferic
Anemia

Latest News

  1. Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

    WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  2. Rockwell Medical, Inc. Expands Medical Capabilities

    – Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov.

  3. Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

    – Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program –  – Signs leading East Coast academic medical center as first

  4. Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference

    WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  5. Rockwell Medical, Inc. to Discuss Third Quarter 2019 Financial Results on November 11, 2019

    WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (NASDAQ:RMTI) today announced that the Company will release its 2019 third quarter financial results on

  6. Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors

    WIXOM, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  7. Rockwell Medical, Inc. Provides Business Update

    –  Encouraging progress for Triferic® portfolio – – Conference call at 8:30 am ET on Friday, October 25, 2019 – WIXOM, Mich., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical"

  8. Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

    WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to

  9. Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors

    WIXOM, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia,

  10. Rockwell Medical, Inc. to Present at Upcoming September Conferences

    WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to